Fibrinogen-fibrin breakdown products in pathologic synovial fluids. An immunologic study.
D000941:Antigens; D001168:Arthritis / Q000378:metabolism; D001172:Arthritis, Rheumatoid / Q000378:metabolism; D002918:Chymotrypsin / Q000494:pharmacology; D005337:Fibrin / Q000378:metabolism*; D005340:Fibrinogen / Q000378:metabolism*; D005341:Fibrinolysin / Q000494:pharmacology; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D010003:Osteoarthritis / Q000378:metabolism; D011479:Protamines / Q000494:pharmacology; D013582:Synovial Fluid / Q000032:analysis*; D013917:Thrombin / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
D000941:Antigens; D011479:Protamines; D005337:Fibrin; D005340:Fibrinogen; D002918:Chymotrypsin; D014357:Trypsin; D013917:Thrombin; D005341:Fibrinolysin